EN
HI
Summary
As of 29 Aug, 2026, Procter & Gamble Health stock price is ₹5670.5. During the trading session, the stock has moved between an intraday low of ₹5640.00 and an intraday high of ₹5750.00. Over the last 52 weeks, Procter & Gamble Health has traded between ₹4707.00 and ₹6975.00.
The stock has recorded a trading volume of 12,108 shares, with a market capitalization of ₹16599382. Its Average Traded Price (ATP) is ₹5679.42, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹5670.50.
Procter & Gamble Health has an upper circuit limit of ₹6804.50 and a lower circuit limit of ₹4536.50. The total value traded stands at ₹6.88 CR, and the delivery percentage for the day is 53.94%.
The stock is currently traded with a market lot size of 1. Procter & Gamble Health also offers a dividend yield of 0%.
Procter & Gamble Health share price chart
Procter & Gamble Health Share Key Metrics
Volume
12108.00
Market Cap
9412.68 CR
LTQ@LTP
1@5670.50
ATP
5679.42
Var Margin
13.33 %
Circuit Range
4536.5-6804.5
Delivery %
53.94 %
Value
6.88 CR
ASM/GSM
No
Market Lot
1
Procter & Gamble Health Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.1
Sector P/B
3.41
Sec. Div. Yield
0.51
Procter & Gamble Health Resistance and Support
Pivot 5739
Resistance
First Resistance
5765
Second Resistance
5807.5
Third Resistance
5833.5
Support
First Support
5696.5
Second Support
5670.5
Third Support
5628
Procter & Gamble Health Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 5750 | 5670.5 | -0.91% | 5750 | 5640 |
| Thu Aug 27 2026 | 5720 | 5722.5 | -0.75% | 5781.5 | 5713 |
| Wed Aug 26 2026 | 5833 | 5766 | -1.15% | 5880 | 5751 |
Procter & Gamble Health Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results & Interim Dividend |
| 2025-08-01 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-04 | Quarterly Results |
Procter & Gamble Health News
Procter & Gamble Health Ltd - 500126 - Record Date For Purpose Of Dividend
Procter & Gamble Health announced August 27, 2026 as record date for final dividend for FY25-26. Eligible shareholders will receive payment by September 27, 2026.
Aug 10 2026 18:53:04
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Procter & Gamble Health announced Q1 FY27 results. Sales grew 7% to Rs.356 crores, driven by strong brand fundamentals. Reported PAT increased 45% to Rs.96 crores, while operational PAT was up 9% to Rs.72 crores, excluding one-time gains.
Aug 06 2026 14:05:49
Read More
Procter & Gamble Health Management
| Name | Position |
|---|---|
| Zeal Rupani | Company Secretary & Compliance Officer |
| S Madhavan | Chairperson |
Procter & Gamble Health Similar Stocks
Suven Life Sciences Ltd.
364.95
-3.15 (0.86%)
Jupiter Life Line Hospitals Ltd.
301.40
-6.05 (1.97%)
Thyrocare Technologies Ltd.
584.35
2.90 (0.50%)
Yatharth Hospital & Trauma Care Services Ltd.
967.40
-5.65 (0.58%)
Strides Pharma Science Ltd.
1019.90
36.90 (3.75%)
Aarti Pharmalabs Ltd.
840.70
27.20 (3.34%)
Sanofi India Ltd.
3181.60
0.60 (0.02%)
Nephrocare Health Services Ltd.
692.35
6.90 (1.01%)
Senores Pharmaceuticals Ltd.
1482.10
7.50 (0.51%)
Kovai Medical Center & Hospital Ltd.
6032.50
18.50 (0.31%)
Procter & Gamble Health FAQs
The Buying Price of Procter & Gamble Health share is 5670.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Procter & Gamble Health stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Procter & Gamble Health, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Procter & Gamble Health shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Procter & Gamble Health shares is 0. Useful to assess the stock's value relative to its book value.
To assess Procter & Gamble Health’s valuation compare Sector P/E, P/B which are 69.1 & 3.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Procter & Gamble Health is 9412.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Procter & Gamble Health share price is 6975.00 & 4707.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Procter & Gamble Health belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
